TP53 and breast carcinoma: Alternatively, Li et al. described that SAHA facilitates the release of mutant p53 from HSP90/HDAC6 complex and thereby promoting its degradation mediated by MDM2 and CHIP in human breast cancer-derived MDA231 cells [45].